Cancer

In the challenging landscape of pancreatic ductal adenocarcinoma (PDAC) treatment, surgical resection remains a cornerstone despite the high risk of...

In a remarkable advance in cancer immunotherapy, a novel targeted immune treatment has brought lasting remission to a patient suffering...

In a landmark advancement poised to reshape prognostic evaluation in epithelial ovarian cancer (EOC), researchers have successfully developed and validated...

In the ever-evolving landscape of lung cancer research, a recent real-world study published in BMC Cancer shines new light on...

In Puerto Rico, colorectal cancer (CRC) stands as the leading cause of cancer-related mortality, presenting a formidable challenge to healthcare...

A groundbreaking international study has revealed that pioglitazone, a drug primarily used in the treatment of type 2 diabetes, may...

In the United States, people living with HIV (PWH) who develop cancer face unique and complex challenges in receiving timely...

In a monumental stride for pediatric cancer research, Charles G. Mullighan, MBBS (Hons), MSc, MD, senior deputy director at the...

A groundbreaking study from the University of Cambridge suggests a novel therapeutic combination that could revolutionize the treatment landscape of...

As the global population ages, the challenge of effectively treating cancer in older adults becomes increasingly urgent. Immunotherapy, particularly CAR-T...

In a groundbreaking advancement in cancer therapy, researchers have unveiled a novel approach that combines microwave-assisted drug delivery with cutting-edge...

A revolutionary stride in lung cancer prediction was unveiled recently at the ATS 2025 International Conference held in San Francisco,...

In a groundbreaking advancement for liver cancer research, scientists have unveiled a novel genetic risk model that links lipid metabolism...

New Insights from Memorial Sloan Kettering Illuminate Immune Defenses, CAR T Cell Side Effects, Metabolic Profiling, and CRISPR Antiviral Mechanisms...

In the relentless pursuit of more effective and less toxic treatments for acute myeloid leukemia (AML), a recent comprehensive meta-analysis...

In the evolving landscape of cancer treatment, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a beacon of hope,...

Researchers at the University of Texas at Dallas, in partnership with scientists from UT Southwestern Medical Center, are pioneering a...

Medulloblastoma stands as one of the most prevalent and devastating brain cancers diagnosed in children worldwide. Among its molecular subtypes,...

The Epstein-Barr virus (EBV), a member of the herpesvirus family, silently infects the majority of the global population, often without...

In a pioneering study published in BMC Cancer, researchers have unveiled significant associations between specific polymorphisms in the MYCN gene...